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Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Australia would assist in evaluating
if this care is effective and meeting patients’ needs. The objective of this study was to obtain and explore the patients’ account of
the technical and interpersonal aspects of melanoma follow-up care received. An online survey was conducted to acquire details
of patients’ experience. Participants were patients treated in Australia for primary melanoma. Qualitative and quantitative data
about patient perceptions of the nature and quality of their follow-up care were collected, including provision of melanoma specific
information, psychosocial support, and imaging tests received. Inconsistencies were reported in the provision and quality of care
received. Patient satisfaction was generally low and provision of reassurance from health professionals was construed as an essential
element of quality of care. “Gaps” in follow-up care for melanoma patients were identified, particularly provision of adequate
psychosocial support and patient education. Focus on strategies for greater consistency in the provision of support, information,
and investigations received, may generate a cost dividend which could be reinvested in preventive and supportive care and benefit
patient well-being.
1. Introduction
Globally, Australia has the highest incidence of melanoma,
with annual rates continuing to rise [1]. Individuals with a
primary melanoma have 8–12% risk of developing a second
primary melanoma and an increased risk of developing a
nonmelanoma skin cancer [2–5], and therefore posttreatment
monitoring for recurrence and new primary melanomas is
important. The purpose of follow-up is to detect recur-
rence and/or progression at an early treatable stage, identify
treatment-related morbidity (e.g., lymphoedema), identify
new melanoma or nonmelanoma skin cancers, and provide
reassurance and education [6]. Good practice in follow-up
includes effective coordination of care, consistency in care
provision [7, 8], evidence-based testing, and psychosocial
support [6–9]. Patient perceptions can provide valuable
insight into the quality of melanoma follow-up care and
identify potential areas for improvement.
Quality of patient care can be defined in both technical
and interpersonal terms [10]. Here, “technical” refers to
best practice based on current evidence coupled with care
providers’ knowledge, judgment, and skill in implementa-
tion [10]. The 2008 Australian Cancer Network Melanoma
Guidelines publication describes best practice guidelines for
melanoma follow-up, including judicious use of imaging and
blood tests, patient education for detection of recurrence
and new primary melanomas, and scheduling follow-up
visits with health professionals, on the basis of stage of the
cancer, familial history, and patient ability to perform self-
examination [6].
The success of technical care depends, in part, on the
management of interpersonal care [10], including factors such
as communication, empathy, and trust. The subjective nature
of interpersonal caremakes it a difficult construct tomeasure;
therefore, “best practice guidelines” in this area can be diffi-
cult to formulate and implement [10]. Patient satisfaction can
be one measure, with self-reported measures of satisfaction
helping to determine the values patients themselves associate
with quality of care [11]. Measures of patient satisfaction
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consist of both cognitive evaluation and emotional response
to the structure and process and outcome of health ser-
vices received [12]. The amount and clarity of information
received correspond with the cognitive evaluation, whilst the
emotional responses encompass psychosocial factors such as
receiving adequate support. The psychosocial interventions
advocated by the 2008 Australia and New Zealand clinical
practice guidelines include cognitive-behavioural group ther-
apy and psychoeducation and access to support groups.
Previous research on melanoma patients’ experiences
in Australia at follow-up consults recommended a tailored
approach to follow-up care with adequate provision of infor-
mation enabling patients to participate in shared decision-
making [9]. Overall high levels of satisfaction with follow-up
care were reported by Morton et al. [9]; however, the sample
was restricted to patients adhering to follow-up schedules in
specialist melanoma centres, potentially targeting only those
patients who had a positive experience. Similarly, a systematic
review of 15 studies examining the psychosocial aspects of
melanoma follow-up care reported high levels of patient
satisfaction although none of the studies were Australian
[13]. Carter et al. argue that effective delivery of follow-up
in Australia and elsewhere is challenging [14]. In particular,
the guidelines are based on low-level evidence leading to
variation in practice. This study was conducted to investigate
if new knowledge in follow-up care in Australia was essential
towards fulfilling the health needs of melanoma patients.
We used an online survey distributed across a variety
of settings, including nonmetropolitan and multistate, for
participant recruitment. Our study aimed to collect the views
of patients with a broad base of experience in melanoma
follow-up care in Australia, investigating patient perceptions
of both the technical and interpersonal aspects of the quality
of their follow-up care.
2. Materials and Methods
2.1. Participants. Purposive sampling ensured that only
patients with experience of melanoma follow-up care par-
ticipated. Participants were patients treated in Australia for
a primary melanoma since 1 January 2007. Selection criteria
excluded patients diagnosed in the previous year, as such
patients were deemed to be in “treatment phase” and not in
follow-up care.
One hundred andfiftypatients accessed the questionnaire
with 33 incomplete surveys and 53 surveys that were excluded
as the participants were diagnosed before 2007. The remain-
ing 64 participants were included ensuring that only current
data on follow-up care was used for this analysis. Patient
characteristics are listed in Table 1.
2.2. Materials. Responses were collected using a web-survey
through SurveyMonkey. An online information sheet pre-
ceded the questionnaire to inform participants about the
study and obtain consent. Anonymity was assured and no
payment was offered.The 40-question survey, predominantly
with “tick box” format, collected information about patient
demographics, nature of the melanoma, treatment details,
and nature of follow-up care, including the Assessment of
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Survivor Concerns, as developed by Gotay and Pagano [15].
A pilot study with 5 melanoma patients recruited through
a surgical oncologist tested the survey before dissemination.
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Pilot study participants emphasised the emotional aspects of
melanoma follow-up care. As a result, additional questions
to assess this factor were included. Free-boxes permitted
participants the opportunity to elaborate on their survey
responses and contribute further comments. These open-
ended comments comprise the study’s qualitative data.
2.3. Procedure. Australian state and national organisations
involved in melanoma care were approached to support the
project ensuring a range of patient experiences, unrestricted
by a single specialist centre. The following organisations
supported advertisement and recruitment through their
websites and networks: Melanoma Patients Australia, the
Cancer Council of South Australia and the Cancer Coun-
cil of Australian Capital Territory, the Australia and New
Zealand Melanoma Trials Group, the Melanoma Institute
Australia, the National Melanoma Symposium (Melbourne,
2012), Melanoma WA, and Sunbedban. An additional media
release in a major South Australian newspaper was also
conducted.
Ethics approval was obtained from the University of
Adelaide Human Research Ethics Committee (number H-
2012-037). Data collection occurred for the period of June-
September, 2012. Analysis was supported by IBM SPSS
version 19, Armonk, NY, USA (quantitative analysis) and
NVivo 10.1 (qualitative analysis) [16].
2.4. Qualitative Analysis. In thematic analysis, as detailed by
Braun and Clarke [17], the data were independently coded
by two authors (Peta Callaghan and Jackie Street) with
iterative discussion to determine concurrence and resolve
discrepancies. After open coding, overarching themes were
derived, condensing smaller categories: for example, cate-
gories relating to mental health and emotional issues, includ-
ing counselling, fear, stress, and need for reassurance were
grouped to form the overarching theme and psychosocial
factors.
We were interested in exploring patients’ experiences of
their care, including information needs, degree of anxiety,
experience of follow-up care, and perspectives on potential
benefit of a follow-up care coordinator. Our analysis therefore
focused on patient experience of melanoma follow-up care.
3. Results
3.1. Patient Satisfaction. Patient satisfaction was determined
by three questions that assessed patient experiences of ade-
quate support during follow-up care, patient satisfaction with
the amount of information received, and patient preferences
for a coordinator to manage follow-up care. Many partici-
pants reported that they did not receive adequate support
during follow-up (51.6%), that they would have liked to
receive more information from their health professionals
(64.1%), and that they would like a coordinator to organise
their melanoma follow-up care (62.5%).
Whilst the categorical nature of our data restricted mul-
tivariate analysis, general response patterns were identified.
Participants not supporting the use of follow-up care coor-
dinators also generally reported receiving adequate support
and being satisfied with information provision from their
health professionals.This trendwas also found in the opposite
direction: participants supporting the use of a coordinator
generally described inadequate support and information
provision during follow-up care.
3.2. Technical Aspects of Quality of Care
3.2.1. Health Professionals Seen and Frequency of Visits. Sur-
geons were the most frequently reported health professional
seen (32 participants), followed by dermatologists (30 partic-
ipants), although 8 patients saw both. Intervals between visits
varied considerably across the patient group; for example,
patients with <1mm melanomas reported being seen 3
monthly. Although 31 patients reported that they regularly
saw a general practitioner, it is possible that the reason for
these visits may not have specifically related to melanoma
follow-up. A minority of participants (22%) reported regular
consults with three or more melanoma specialists.
3.2.2. Diagnostic Tests. In follow-up care (after the initial
12-month treatment phase), the most common diagnostic
test described was a computed tomography (CT) scan (41
participants), followed by positron emission tomography
(PET) scans (17 participants) and chest X-rays (CXR) (11
participants). Several patients indicated a preference to have
more scans during follow-up care. Patients constructed the
provision of more scans as a means of reassurance (Box 1).
Patient awareness of the superiority of self-examination to
monitor future risk was not reflected strongly in our data
with only one participant explicitly reporting conducting
their own skin checks. Comments from many participants
indicated that theywere unaware of the benefits of skin checks
or how to perform adequate self-examination.
3.3. Interpersonal Aspects of Quality of Care. In line with
previous research, the most common type of dissatisfac-
tion expressed was with the type of communication and
information offered [11]. Sixty-four percent of participants
reported they would have liked more information about
melanoma, and comments about the quantity and quality of
communication dominated the qualitative data.
3.3.1. Information Received. For many participants (40.6%)
websites were themain sources of information onmelanoma,
with the second main source being surgeons (25%). Nearly
half of the participants (46.9%) reported not receivingwritten
information, and around 70% reported receiving no informa-
tion on cancer services, patient support websites, or generic
sun protection measures (e.g., avoidance of solariums, use
of sunscreens). Thirty-eight participants (59.4%) received a
copy of their melanoma pathology report, but only 3 (4.7%)
received a written follow-up plan. Box 1 provides examples of
participants’ comments about information provision. Lack of
information was the most commonly reported theme in this
category; however, conflicting information and the need for
ongoing information due to “forgetting” were also reported.
3.3.2. Communication. Communication was constructed in
2 primary ways: communication between professionals
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A preference for monitoring through imaging
. . .I had heard that there are scanners that they run over your body and somehow it lights up to see if there are any melanoma,
I have asked about this and was told that I would have to go to a private clinic that would cost way too much,
I just can’t afford it at all. Why can’t the hospital have equipment like that? [female, 21 yrs]
Regarding the provision of information
Lack of information
. . .I was not given information. . . all information I was given in written form was something I had to request. . . I never received
anything from my dermatologist or surgeon. [female, 33 yrs]
. . .no support or any information. . . [male, 45 yrs]
I was not given information about metastatic melanoma—I had to google this. I was not told about survival rates. I was not
told about recurrence rates. [female, mother of three young children, 33 yrs]
Conflicting information
I’ve been given conflicting information about what treatment is available to me. [female, 39 yrs]
. . .it seems to me that cancer information and resources are quite disjointed nationally. If I were to move interstate I’d have
no idea where to go for a scan. [female, 45 yrs]
Forgotten information
Telling me things at the time of diagnosis, (and even for my husband who was with me) it was hard to remember exactly
what was being communicated beyond dates and times and requirements for surgery and so forth. . .There were a million
details and it seemed the things we would need to know later were the things we forgot in the explosion of activity
and emotion surrounding the initial treatment. . . [female, 45 yrs]
Communication
Poor communication
. . .there is poor communication between the surgeon and my GP as to how to treat and care for my problem [female, 25 yrs]
. . .hospitals seem to have a silo mentality, that is, they do not share information. [male, 43 yrs]
Ideal communication
I would probably be reassured if there was a single person who was coordinating my care and who I could
communicate with as a single point of contact. [female, 42 yrs]
GPs and medical surgeons and specialists have a duty of care to their patients, and that includes communicating with
their patient regarding follow up care, and communicating with one another as health care professionals. [female, 52 yrs]
Good communication
My doctors and surgeons have been very supportive and accommodating with their time and explanations. [female, 39 yrs]
My oncologist and [I] have excellent communication channels. However, when I have been referred to the public system that
standard of communication deteriorates. The public system is obviously
stretched and personal follow-up and communication is lost. [male, 52 yrs]
A change in health professional
I go to a different clinic from the original one that removed the melanoma. I am scarred mentally and physically as the
wound came open after stitches were removed and they did not care or offer treatment. . . Am happy with new clinic and
they are appalled at my scar and lack of treatment I received. [female, 47 yrs]
. . .the doctors at the . . . Clinic show little inclination to want to answer questions at all. I have now switched treatment centres
and find that the approach by the oncologists there is much better. [male, 43 yrs]
Preferences for follow-up care coordination
Coordination is a good thing
To ensure all options and information is presented. . . [male, 36 yrs]
. . .to have a point of contact as to what I should be doing and who to
follow up with would be extremely valuable. [male, 45 yrs]
I can manage, however coordination may be helpful for others
I am confident enough to coordinate my own appointments and tests, however this would be an excellent idea for patients
without the same confidence. [female, 63 yrs]
Maybe for aged patients with other challenges. I prefer to self-manage. [male, 47 yrs]
Psychosocial factors
Emotional aspects
I was offered no follow up care. . . I was afraid and didn’t have a lot of knowledge as to what was happening [female, 21 yrs]
Emotional stress was worse than physical symptoms. [female, 46 yrs]
Just waiting for it to come back, not keen on that. [male, 46 yrs]
Therapy/counselling
. . .If after initial melanoma removed and so forth an actual face to face appointment is made with a counsellor/support
service by the surgeon/doctor. . . Sometimes you just need to talk to someone. . . [female, 42 yrs]
. . .lack of mental health care surrounding the diagnosis. [female, 38 yrs]
Box 1: Examples of participant comments.
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and communication with professionals. Within these cate-
gories, three themes were expressed: poor communication,
ideal communication, and good communication with poor
communication reported as the most common experience
(Box 1). Many participants described the type of commu-
nication they felt should happen. Ideal communication was
frequently constructed in terms of “reassurance” for patients.
The lack of information (received or perceived) meant many
participants accessed information themselves via the Inter-
net; however, participants also indicated that poor commu-
nication with their health care professional meant they often
did not know what to look for or which information applied
to them.
3.3.3. Changed Professionals. Four participants voluntarily
reported having changed health professionals due to dissatis-
faction with quality of care, a finding in accord with previous
research [11, 18]. Interestingly, each of these participants
also reported satisfaction with the care provided by their
subsequent health professional.
3.3.4. Psychosocial Factors. With respect to patients’ fears
and concerns, 29 (45.3%) participants reported that they
received inadequate support. Concern was highest in relation
to cancer recurrence and the impact on their children’s
health. Having a coordinator (defined as a person to assist
in organising follow-up care) was valued by 40 (62.5%)
participants. The qualitative analysis supports this finding
withmany participants equating coordinationwith improved
support and information provision.Whilst some participants
felt that they themselves did not require a coordinator, for
a few participants this was constructed as entirely due to
personal characteristics: these participants reported that they
were organised and were confident. Strong support for a
care coordinator in concert with concerns about gaps in
care and communication (Box 1) indicates that, for these
participants, structural support for melanoma follow-up care
within the health care system was inadequate. In addition,
participants indicated (Box 1) that lack of consistent support
and information compounded the stress and fear associated
with melanoma follow-up. Moreover, provision of reassur-
ance fromhealth professionalswas constructed as an essential
element of quality of care.
4. Discussion
4.1. Patient Satisfaction with Quality of Care. Unlike previous
research into patient perceptions of the quality of melanoma
follow-up care in Australia [9], our findings indicate con-
siderable dissatisfaction with the quality of care received.
The sampling of patients via websites and online support
groups provides a cohort of melanoma patients including
more nonmetropolitan participants and participants from
multiple states than those reported in Morton et al., where
participants were recruited from a specialist follow-up centre
[9].
The findings suggest that there was considerable variabil-
ity in perceived quality of care, and for many participants in
our study, psychosocial support and information provision
were inadequate. Both factors appeared to affect patients’
sense of control, a finding mirrored in previous research [13].
4.2. Technical Aspects of Care. This study also identified
considerable variance in follow-up practice in our partic-
ipants’ group with variation in the types of doctors seen
and frequency of visits and indications of duplication of
care. This finding mirrors a 2011 Netherlands study, where
patients were reportedly receiving more follow-up visits than
being clinically indicated [7]. In addition, Australian and
NewZealand guidelines recommend that patients themselves
should play a central role in monitoring for recurrence or
new primary melanomas. Our findings suggest that essential
education for self-examination, to support such monitoring,
may be lacking.
The Australian and New Zealand guidelines do not
recommend radiological tests (CXR, CT, and PET) in early
stage melanoma [6] with the evidence indicating that routine
imaging has minimal value in follow-up, and the additional
cost cannot be justified [6, 19]. Some participants reported
they would like more testing, and others reported excessive
testing across the spectrum of disease. However, our findings
must be interpreted with caution, as assessing the “appropri-
ateness” of imaging for each patient (e.g., based on patient,
tumour, and treatment characteristics) was beyond the scope
of this study.
4.3. Interpersonal Aspects of Care. Our findings indicate that
adequate provision of information was lacking for many
patients. Lack of information and poor communication were
associated with seeking information online, but this did not
always provide an adequate alternative. High internet usage
for unmet needs has been reported elsewhere [20] and attests
to the desire of patients to be fully informed.
Participants reporting they had forgotten information
used the terms “explosion” and “shock” (Box 1), suggesting
intense emotional reaction to diagnosis of melanoma, may
make it difficult to retain information provided. Patients may
not recall information received during this time. Previous
studies have indicated the need for ongoing tailored discus-
sions with patients about their care throughout the “cancer
journey” [21, 22].
Patient fears for their children’s health and their own can-
cer recurring are reasonable given the evidence of recurrence
risk and familial predisposition [6, 23]. Despite evidence
that such concerns may be decreased with education and
support [23, 24], our study suggests that many patients
with melanoma receive inadequate support for psychosocial
issues. Oliveria et al. showed that patient perceptions of
inadequate support through the health care system could
lead to suboptimal health outcomes [25]. Provision of a care
coordinator, expressed as being of value by over half of the
study participants, has been demonstrated to improve health
outcomes in breast cancer patients [26] andmay go someway
to providing mental and emotional support.
5. Limitations
The online nature of the study presents selection bias and
although potentially widely accessible across Australia, the
number of participants was small. Therefore, the findings
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may not be representative of national experience of patients
undergoing melanoma follow-up. As a retrospective study,
the possibility of recall bias is also acknowledged. Reliance on
categorical data limited analysis, making it difficult to assess
relationships amongst variables.
6. Conclusion
This study provides insights into the nature of melanoma
follow-up care in Australia. We identify perceived gaps in
patient care, perceptions of inadequate support and informa-
tion, and variance in patterns of care, all of which suggest
that the quality and consistency of melanoma follow-up care
in Australia can be improved. Moreover, follow-up care is
iterative and the needs of patients, including information,
emotional support, and medical care, may be very different
from their needs during the treatment phase. According to
our data, it appears that these changing needs are not being
widely addressed. Moreover, the variation in patterns of care
suggests the Australian and New Zealand clinical practice
guidelines are not being consistently followed. Our data
suggest that provision of targeted support and information
from health professionals may improve long-term patient
self-care. Whilst this finding deserves greater attention in
future research, we also suggest that a focus on developing
strategies for generating greater adherence to the clinical
guidelines, including the stringent use of investigations as
recommended, may generate a cost dividend which could be
reinvested in preventive and supportive care. We suggest that
greater consistency in the provision of emotional support and
information throughout treatment and follow-up phases of
melanoma follow-up care could enhance patient well-being.
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